(lp0
S'BG Medicine: Nearing The Finish Line Seeking Alpha - Dec 3, 2015 When BG Medicine  went public nearly a half decade ago, it did so with much fanfare and hope for the future of its FDA approved Galectin-3 test to predict heart failure in individuals already diagnosed with the disease.'
p1
aS"In Volatile Markets Do Analysts Think You Should Buy BG Medicine, Inc. ? The De Soto Edge - 22 hours ago 11/13/2014 - BG Medicine, Inc. was downgraded to  by analysts at Ladenburg Thalmann. The share price of BG Medicine, Inc.  was up +9.86% during the last trading session, with a day high of 0.08. 500 shares were traded on BG Medicine, Inc.'s&nbsp;...Is There a Spark Ahead for BG Medicine, Inc. ? - Morgan Research"
p2
aS'Why BG Medicine  Is Up Today TheStreet.com - Jan 28, 2014 &quot;We rate BG MEDICINE INC  a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we&nbsp;...'
p3
aS'BG Medicine  Seeks Additional Indication from FDA for BGM Galectin-3 Test StreetInsider.com - Mar 31, 2015 BG Medicine, Inc. , the developer of the BGM Galectin-3 Test, today reported that it has filed a 510 Premarket Notification with U.S.'
p4
aS'BG Medicine  Reports FDA Clearance of Automated Galectin-3 Testing  StreetInsider.com  - Dec 30, 2014 BG Medicine, Inc.   is the developer of the BGM Galectin-3 Test, which is the FDA-cleared manual microtiter plate version of the galectin-3 test, and the licensor of this first automated galectin-3 assay, which is used with ...'
p5
aS'BG Medicine  Stock Declines | Earnings Report Released CNA Finance  - Mar 31, 2015 BGMD Stock News BG Medicine, Inc.  BG Medicine stocks fell in a big way in morning trading today after the company released its earnings report before the bell.'
p6
aS'What Are Institutions Doing With This Stock: BG Medicine, Inc.  Winfield Review - 16 hours ago Institutions on the Buy-Side have decreased the number of transactions in BG Medicine, Inc.  shares over the past quarter according to the latest SEC Filings.'
p7
aS"BG Medicine, Inc.  Average Rating At 0 Markets Daily - Feb 17, 2017 BG Medicine, Inc. was given a 100 for the session as on 2017-02-17. The mechanism of computationally listing and conveying pinions in news articles, especially to highlight the writer's outlook, whether it is neutral, negative or positive, listed on ..."
p8
aS'First Automated Test for Galectin-3 Now Available in US GlobeNewswire  - Jul 6, 2015 WALTHAM, Mass., July 6, 2015  -- BG Medicine, Inc. , the developer of the BGM Galectin-3 Test, today announced that the ARCHITECT Galectin-3 assay is now available.'
p9
aS'BG Medicine  Declines On Dilution Fears CNA Finance  - Aug 13, 2015 BG Medicine, Inc.  This morning, BG Medicine announced the price of an underwritten public offering of its equity securities; declining dramatically as investors fear dilution.'
p10
a.